Clinical Study
Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
Table 1
Distribution of patients by age and sex.
| | Baseline characteristic | Efficacy-evaluable population () | Intent-to-treat population () |
| | Age category, (%) | | | | Pediatric (2 to <15 years) | 187 (39%) | 190 (38%) | | 2 to <5 years | 19 (4%) | 19 (4%) | | 5 to <15 years | 168 (35%) | 171 (35%) | | Adult (≥15 to 55 years) | 292 (61%) | 304 (62%) | | Sex, n (%) | | | | Male | 295 (62%) | 304 (62%) | | Female | 184 (38%) | 190 (38%) |
|
|
